Skip to main content

RAFFA WEALTH MANAGEMENT, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1631073 WASHINGTON, DC

Position in NBIX

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$4,044
+$1,410 QoQ
Shares Held
24
+20.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#715
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

RAFFA WEALTH MANAGEMENT, LLC holds $34,977 across 13 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (11.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
24 $4,044

All Filings in NBIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,044 24
2026-03-31 $2,634 20
2025-12-31 $2,694 19
2025-09-30 $2,667 19
2025-06-30 $2,388 19
2025-03-31 $2,101 19
2024-12-31 $2,593 19
2024-09-30 $2,189 19
2024-06-30 $2,615 19
2024-03-31 $2,620 19
2023-12-31 $2,503 19
2023-09-30 $2,137 19
2023-06-30 $1,791 19
2023-03-31 $1,923 19
2022-12-31 $2,269 19
2022-09-30 $2,017 19
2022-06-30 $1,852 19
2022-03-31 $1,781 19
2021-12-31 $1,618 19
2021-09-30 $1,822 19
2021-06-30 $1,849 19
2021-03-31 $1,847 19
2020-12-31 $1,246 13
2020-09-30 $1,250 13
2020-06-30 $1,586 13
2020-03-31 $1,125 13